Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin in BPH-related LUTS
NCT00409357Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00409357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409357.